Company news
Invo Fertility, Inc. (NASDAQ:IVF) news
Invo Fertility, Inc. news releases on 6ix. Latest, Nov 13, 2023: INVO Reports Record Third Quarter 2023 Financial Results
Press releases — page 2
INVO Reports Record Third Quarter 2023 Financial Results
November 12, 2023
NAYA Biosciences and INVO Bioscience Announce Appointment of Dr. Peter Kash, Ed.D., MBA as Vice Chairman Following Closing of Their Pending Merger
November 9, 2023
INVO Bioscience Announces Commencement of Waiver Solicitation From Holders of the Company's Common Stock Purchase Warrants
November 8, 2023
INVO Bioscience and NAYA Biosciences Announce Definitive Merger Agreement To Establish Expanded Publicly Traded Life Science Company
October 22, 2023
INVO to Participate in the Lytham Partners Fall 2023 Investor Conference
October 10, 2023
INVO BIOSCIENCE ANNOUNCES ADJOURNMENT OF SPECIAL MEETING OF SHAREHOLDERS
September 28, 2023
INVO Reminds Shareholders to Cast Their Vote for Upcoming Special Meeting of Shareholders to be held on Friday, September 29, 2023 at 12:00 p.m. ET
September 27, 2023
INVO Reports Second Quarter 2023 Financial Results
August 13, 2023
INVO Closes Acquisition of Wisconsin Fertility Institute
August 10, 2023
INVO to Report Second Quarter 2023 Financial Results on Monday, August 14, 2023
August 8, 2023
INVO Bioscience Announces Closing of $4.5 Million Public Offering
August 7, 2023
INVO Bioscience Announces Pricing of $4.5 Million Public Offering
August 3, 2023
INVO Sets Revised Closing Date of Wisconsin Fertility Institute Acquisition and Announces Key Operational Trends to Drive Shareholder Value
August 2, 2023
INVO Announces a 1:20 Reverse Stock Split Effective Pre-Market Opening on July 28, 2023
July 26, 2023
INVO Receives 510(k) FDA Clearance for Expanded Use of the INVOcell Device
June 26, 2023
INVO Reports First Quarter 2023 Financial Results
May 14, 2023
INVO Bioscience to Report First Quarter 2023 Financial Results on Monday, May 15, 2023
May 7, 2023
INVO Reports Fourth Quarter and Full Year 2022 Financial Results
April 16, 2023
INVO Bioscience to Report Fourth Quarter and Fiscal Year 2022 Financial Results on Monday, April 17, 2023
April 10, 2023
INVO Congratulates Wisconsin Fertility Institute on Being Named One of America's Best Fertility Clinics by Newsweek
April 4, 2023
INVO Provides Preliminary Update on FY2022 Financial Results
March 29, 2023
INVO Bioscience Announces Closing of $3.0 Million Registered Direct Offering
March 26, 2023
INVO Bioscience Announces Pricing of $3.0 Million Registered Direct Offering Priced At-The-Market
March 23, 2023
INVO Signs Binding Agreements to Acquire Wisconsin Fertility Institute
March 19, 2023
INVO Bioscience Enters Distribution Agreement for Taiwan
January 4, 2023
INVO Bioscience Engages Nationally Recognized Physician for New Tampa-based INVO Center
January 2, 2023
First Baby Born in Malaysia Utilizing Innovative INVOcell Assisted Reproductive Technology
November 29, 2022
INVO Bioscience Reports Third Quarter 2022 Financial Results
November 13, 2022
INVO Bioscience to Report Third Quarter 2022 Financial Results on Monday, November 14, 2022
November 9, 2022
INVO Bioscience Highlights INVOcell Progress From the 2022 American Society for Reproductive Medicine (ASRM) Congress & Expo
October 31, 2022
INVOcell Review Published in Current Opinion in Obstetrics and Gynecology
October 20, 2022
INVO Bioscience to Exhibit at the 2022 American Society for Reproductive Medicine (ASRM) Congress & Expo
October 16, 2022
Dr. Sue Ellen Carpenter of INVO Bioscience's Atlanta-based INVO Center - Bloom Fertility - Named Top Doctor by Castle Connolly
September 21, 2022
INVOcell Launched in Malaysia by Advanced Reproductive Centre, Hospital Canselor Tuanku Muhriz
August 24, 2022
INVO Bioscience Reports Second Quarter 2022 Financial Results
August 14, 2022
INVO Bioscience to Report Second Quarter 2022 Financial Results on Monday, August 15, 2022
August 3, 2022
INVO Bioscience Announces "Get to Know INVOcell" - a Series of Facebook Live Events Supporting Access to Affordable Fertility Treatment
July 6, 2022
INVO Signs Distribution Agreement with Onesky Holding Limited for Mainland China
May 15, 2022
INVO Bioscience Reports First Quarter 2022 Financial Results
May 15, 2022
INVO Bioscience to Report First Quarter 2022 Financial Results on Monday, May 16, 2022
May 8, 2022
INVO Celebrates National Infertility Awareness Week at the INVO Center in Atlanta, Georgia
April 27, 2022
INVO Selects Kansas City as additional INVO Center Location
April 13, 2022
INVO Bioscience to Participate in the Lytham Partners Spring 2022 Investor Conference
April 3, 2022
INVO Bioscience Reports 2021 Financial Results
March 30, 2022
INVO Bioscience to Report Fourth Quarter and Fiscal Year 2021 Financial Results on Thursday, March 31, 2022
March 23, 2022
INVO Bioscience to Exhibit at the 2022 Pacific Coast Reproductive Society (PCRS) Annual Meeting
March 23, 2022
INVO Bioscience to Participate in Roundtable Discussion at the 2022 Virtual Growth Conference Presented by Maxim Group LLC and Hosted by M-Vest
March 21, 2022
New Birmingham INVO Center Offers Families an Affordable Advanced Fertility Treatment Solution to Help Combat Rising Costs
March 9, 2022
INVO to Launch Additional INVO Center in Tampa, Florida
February 15, 2022
INVO Bioscience Eyes +20 U.S. Cities To Expand Rollout Of Advanced Infertility Treatment 'INVO Centers'
February 8, 2022